Skip to main content
SpringerLink
Log in

Myelofibrosis: pathogenesis of myelofibrosis with myeloid metaplasia

  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Abina A, Villeval JL, Cohen-Solal K, Vainchenker W, Wendling F, Haddada H, Tulliez M (1997) Myélofibrose par excès de thrombopoiètine. Médecine/Sciences 13:1053

    Google Scholar 

  2. Allouche M (1995) Basic fibroblast growth factor and hematopoiesis. Leukemia 9:937

    PubMed  CAS  Google Scholar 

  3. Anderson JE, Sale G, Appelbaum FR, Chauncey TR, Storb R (1997) Allogeneic bone marrow trans plantation for primary myelofibrosis secondary to polycythaemia vera or essential thrombocytosis. Br J Haematol 98:1010

    PubMed  CAS  Google Scholar 

  4. Argano SAP, Tobin MS, Spain DM (1969) Experimental induction of myelofibrosis with myeloid metaplasia. Blood 33:851

    PubMed  CAS  Google Scholar 

  5. Armstrong E, Vainikka S, Partanen J, Korhonen J, Alitalo R (1992) Expression of fibroblast growth factor receptors in human leukemia cells. Cancer Res 52:2004

    PubMed  CAS  Google Scholar 

  6. Asimakopoulos FA, Green AR (1996) Deletions of chromosome 20q and the pathogenesis of myeloproliferative disorders. Br J Haematol 95:219

    PubMed  CAS  Google Scholar 

  7. Avivi A, Zimmer Y, Yagon A, Yarden Y, Givol D (1991) Flg-2, a new member of the family of fibroblast growth factor receptors. Oncogene 6:1089

    PubMed  CAS  Google Scholar 

  8. Abraham H, Banu N, Scadden DT, Abraham J, Groopman JE (1994) Modulation of megakaryocytopoiesis by human basic fibroblast growth factor. Blood 83:2126

    PubMed  Google Scholar 

  9. Barosi G, Berzuini C, Liberate, LN, Costa A, Polina G, Ascari E (1988) A prognostic classification of myelofibrosis with myeloid metaplasia. Br J Haematol 70:397

    PubMed  CAS  Google Scholar 

  10. Barosi G, Ambrosettti A, Centra A, Falcone A, Finelli C, Foa P, Grossi A, Guarnone R, Rupoli S, Luciano L, Petti MC, Pogliani E, Russo D, Ruggeri M, Quaglini for the Italian Cooperative Study Group on Myelofibrosis with Myeloid Metaplasia (1998) Splenectomy and risk of blast transformation in myelofibrosis and myeloid metaplasia. Blood 91:3630

    PubMed  CAS  Google Scholar 

  11. Battegay EJ, Thomssen C, Nissen C, Gudat E, Speck B (1989) Endogenous megakaryocyte colonies from peripheral blood in precursor cell. Eur J Haematol 42:321

    PubMed  CAS  Google Scholar 

  12. Brogi E, Wu T, Namiki A, Isner JM (1994) Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells whereas hypoxia upregulates VEGF expression only. Circulation 90:649

    PubMed  CAS  Google Scholar 

  13. Brouty-Boyé D, Doucet C, Clay D, Le Bousse-Kerdilès MC, Lampilis TJ, Azzarone B (1998) Phenotypic diversity in human fibroblasts from myelometaplasic and non-myelometaplasic hematopoietic tissues. Int J Cancer 76:767

    PubMed  Google Scholar 

  14. Brunner G, Nguyen H, Gabrilove JL, Rifkin DB, Wilson EL (1993) Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells. Blood 81:631

    PubMed  CAS  Google Scholar 

  15. Bruno E, Cooper RJ, Wilson EL, Gabrilove JL, Hoffman R (1993) Basic fibroblast growth factor promotes the proliferation of human megakaryocyte progenitor cells. Blood 82:430

    PubMed  CAS  Google Scholar 

  16. Buhr T, Georgii A, Choritz H (1993) Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover classification. Pathol Res Pract 189:121

    PubMed  CAS  Google Scholar 

  17. Burkhardt R, Frisch B, Bard B (1982) Bone marrow biopsy in haematological disorders. J Clin Pathol 35:257

    PubMed  CAS  Google Scholar 

  18. Buschle M, Janssen JWG, Drexler H, Lyons T, Anger B, Bartram CR (1988) Evidence for pluripotent stem cell origin of idiopathic myelofibrosis: clonal analysis of a case characterized by a N-ras gene mutation. Leukemia 2:658

    PubMed  CAS  Google Scholar 

  19. Caligaris Cappio F, Vigliani R, Novarino A, Camussi G, Campana D, Gavosto F (1981) Idiopathic myelofibrosis: a possible role for immune-complexes in the pathogenesis of bone marrow fibrosis. Br J Haematol 49:17

    Google Scholar 

  20. Cashman JD, Eaves AC, Raines EW, Ross R, Eaves CJ (1990) Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-β. Blood 75:96

    PubMed  CAS  Google Scholar 

  21. Castro-Malaspina H (1984) Pathogenesis of myelofibrosis: role of ineffective megakaryopoiesis and megakaryocyte components. In: Berck P, Castro-Malaspina H, Wasserman LR (eds) Myelofibrosis and the biology of connective tissue. Liss, New York, p 427

    Google Scholar 

  22. Castro-Malaspina H, Gay RE, Thanwar SL (1982) Characteristics of bone marrow fibroblast colony forming cells and their progeny in patients with myeloproliferative disorders. Blood 59:1046

    PubMed  CAS  Google Scholar 

  23. Castro-Malaspina H, Rabbelino EM, Yen A, Nachman RL, Moree MA (1981) Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts. Blood 57:781

    PubMed  CAS  Google Scholar 

  24. Cervantes F, Pereira A, Esteve J, Rafel M, Cobo F, Rozman C, Momserra E (1997) Identification of short-lived and long-lived patients at presentation of idiopathic myelofibrosis. Br J Haematol 97:635

    PubMed  CAS  Google Scholar 

  25. Chikkappa G, Carsten AL, Chanana AD, Chandra P, Cronkite EP (1978) Increased granulocytic, erythrocytic and megakaryocytic progenitors in myelofibrosis with myeloid metaplasia. Am J Hematol 4:121

    PubMed  CAS  Google Scholar 

  26. Cocault L, Le Bousse-Kerdilès C, Flon M, Challier C, Clay D, Martyré MC, Souyri M (1998) TPO, c-mpl and megakaryocytes in idiopathic myelofibrosis.Abstracts of the European Working Group on Myeloproliferative disorders of the European Haematology Association, Rotterdam, March 12–14, 1998

  27. Cripe LD, Hromas R (1998) Malignant disorders of megakaryocytes. Semin Hematol 35:200

    PubMed  CAS  Google Scholar 

  28. Dalley A, Smith JM, Reilly JT, MacNeil S (1996) Investigation of calmodulin and basic fibroblast growth factor (bFGF) in idiopathic myelofibrosis: evidence for a role of extracellular calmodulin in fibroblast proliferation. Br J Haematol 93:856

    PubMed  CAS  Google Scholar 

  29. Dameshek W (1951) Some speculations on the myeloproliferative syndromes. Blood 6:372

    PubMed  CAS  Google Scholar 

  30. DeCoteau JF, Knaus PI, Yankelev H, Reis MD, Lowsky R, Lodish HF, Kadin ME (1997) Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 94:5877

    PubMed  CAS  Google Scholar 

  31. Dionne CA, Crumley G, Bellot F, Kaplow JM, Searfoss G, Ruta M, Burgess WH, Jaye M, Schlessinger J (1990) Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO 19:2685

    Google Scholar 

  32. Dokal I, Jones L, Deenmamode M, Lewis SM, Goldman JM (1989) Allogenic bone marrow transplantation for primary myelofibrosis. Br J Haematol 71:158

    PubMed  CAS  Google Scholar 

  33. Douay L, Laporte JP, Lefrançois G, Najman A, Dupuy-Montbrun MC, Lopez M, Giarratana MC, Gorin NC (1978) Blood and spleen haematopoiesis in patients with myelofibrosis. Leuk Res 8:725

    Google Scholar 

  34. Douer D, Fabian I, Cline MJ (1983) Circulating pluripotent haemopoietic cells in patients with myeloproliferative disorders. Br J Haematol 54:373

    PubMed  CAS  Google Scholar 

  35. Dronet L, Praloran V, Cywiner-Golenzer C, Trehen C, Flandrin G, Caen JP (1981) Déficit congénital en alpha granules plaquettaires et fibrose réticulinique médullaire. Hypothèse physiopathogénique. Nouv Rev Fr Hématol 23:95

    Google Scholar 

  36. Dupriez B, Morel P, Demory JL, Lai JL, Simon M, Plantier I, Banters F (1996) Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. Blood 88:1013

    PubMed  CAS  Google Scholar 

  37. Eastham JM, Reilly JT, MacNeil S (1994) Raised urinary calmodulin levels in idiopathic myelofibrosis: possible implications for the aetiology of fibrosis. Br J Haematol 86:668

    PubMed  CAS  Google Scholar 

  38. Eaves C, Udomsakdi C, Cashman J, Barnett M, Eaves A (1993) The biology of normal and neoplastic stem cells in CML. Leuk Lymphoma 11:245

    PubMed  Google Scholar 

  39. Edwards DR, Murphy G, Reynolds JJ, Whitman SE, Docherty AJP, Angel P, Heath JK (1987) Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6:1899

    PubMed  CAS  Google Scholar 

  40. Folkman J, Shing Y (1992) Angiogenesis. J Biol Chem 267:10931

    PubMed  CAS  Google Scholar 

  41. Gabbianelli M, Sargiacomo M, Pelosi E, Testa U, Isacchi G, Peschle C (1990) “Pure” human hematopoietic progenitors: permissive action of basic fibroblast growth factor. Science 249:1561

    PubMed  CAS  Google Scholar 

  42. Gabrilove JL, White K, Rahman Z, Wilson EL (1994) Stem cell factor and basic fibroblast growth factor are synergistic in augmenting committed myeloid progenitor cell growth. Blood 83:907

    PubMed  CAS  Google Scholar 

  43. Gabrilove JL, Wong G, Bollenbacher E, White K, Kojima S, Wilson EL (1993) Basic fibroblast growth factor counteracts the suppressive effect of transforming growth factor-β1 on human myeloid progenitor cells. Blood 81:909

    PubMed  CAS  Google Scholar 

  44. Gallicchio VS, Hughes NK, Hulette BC, DellaPuca R, Noblitt L (1991) Basic fibroblast growth factor (bFGF) induces early and late-stage hematopoietic progenitor cell colony formation (CFU-gm, CFU-meg, and BFUe) by synergizing with GM-CSF, Meg-CSF, and erythropoietin, and is a radioprotective agent in vitro. Int J Cell Cloning 9:220

    PubMed  CAS  Google Scholar 

  45. Gay S, Gay RE, Prehal JT (1984) Immunchistological studies of bone marrow collagen. In: Berck P, Castro-Malaspina H, Wasserman LR (eds) Myelofibrosis and the biology of connective tissue. Liss, New York, p 291

    Google Scholar 

  46. Gilbert HS, Praloran V, Stanley ER (1989) Increased CSF-l (M-CSF) in myeloproliferative disease: association with myeloid metaplasia and peripheral bone marrow extension. Blood 74:1231

    PubMed  CAS  Google Scholar 

  47. Gordon BR, Coleman M, Kohen P, Day NK (1981) Immunological abnormalities in myelofibrosis with activation of the complement system. Blood 5:904

    Google Scholar 

  48. Guardiola P, Espérou H, Cazals-Hatarn D, Ifrah N, Jouet JP, Buzyn A, Sutton L, Gratecos N, Tilly H, Lioure B, Gluckman E (1997) Allogeneic bone marrow transplantation for agnogenic myeloid metaplasia. Br J Haematol 98:1004

    PubMed  CAS  Google Scholar 

  49. Han ZC, Bellucci S, Wan HY, Caen JP (1992) New insights into the regulation of megakaryocytopoiesis by haemopoietic and fibroblastic growth factors and transforming growth factor beta-1. Br J Haematol 81:1

    PubMed  CAS  Google Scholar 

  50. Han ZC, Brière J, Nedellec G, Abgrall JF, Sensébé L, Parent D, Guern G (1988) Characteristics of circulating megakaryocyte progenitors (CFU-MK) in patients with primary myelofibrosis. Eur J Haematol 40:130

    PubMed  CAS  Google Scholar 

  51. Hasselbalch HC (1990) Idiopathic myelofibrosis. A clinical study of 80 patients. Am J Hematol 34:291

    PubMed  CAS  Google Scholar 

  52. Hasselbalch HC (1993) Idiopathic myelofibrosis. Clinical aspects and studies on extracellular matrix metabolism. Dan Med Bull 40:39

    PubMed  CAS  Google Scholar 

  53. Hasselbach H, Jans H, Nielsen PL (1987) A distinct subtype of idiopathic myelofibrosis with bone marrow features mimicking hairy cell leukemia: evidence of an autoimmune pathogenesis. Am J Hematol 25:225

    Google Scholar 

  54. Hatzfeld J, Li M, Brown EL, Sookdeo H, Levesque JP, O'Toole T, Gurney C, Clark SC, Hatzfeld A (1991) Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor β1 or Rb oligonucleotides. J Exp Med 174:92

    Google Scholar 

  55. Heuck G (1879) Zwei Fälle von Leukämie mit eigentümlichem Blut- bzw. Knochenmarksbefund. Virchows Arch [A] 79:475

    Google Scholar 

  56. Hibbin JA, Njoku OS, Matures E, Lewis SM, Goldman JM (1984) Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders. Br J Haematol 57:495

    PubMed  CAS  Google Scholar 

  57. Hino M, Tojo A, Miyazono K, Urabe A, Takaku F (1988) Effects of type β transforming growth factors on haematopoietic progenitor cells. Br J Haematol 70:143

    PubMed  CAS  Google Scholar 

  58. Hooper CW (1991) The role of transforming growth factor-beta in hematopoiesis. A review. Leuk Res 15:179

    PubMed  CAS  Google Scholar 

  59. Horikawa Y, Matsumura J, Hashimoto K, Shiraga M, Kosugi S, Tadokoro S, Kato T, Miyazaki H, Tomiyama Y, Kurata Y, Matsuzawa Y, Kanakura Y (1997) Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia. Blood 90:4031

    PubMed  CAS  Google Scholar 

  60. Ignotz R, Massague J (1986) Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261:4337

    PubMed  CAS  Google Scholar 

  61. Iki S, Yagisawa M, Obbayashi Y Sato M, Urabe A (1991) Adverse effect of erythropoietin in myeloproliferative disorders. Lancet 1:187

    Google Scholar 

  62. Jacobson RJ, Salo A, Fialkow PJ (1978) Agnogenic myeloid metaplasia: a Conal proliferation of haematopoietic stem cells with secondary myelofibrosis. Blood 51:189

    PubMed  CAS  Google Scholar 

  63. Kahn A, Bernard JF, Cottreau D, Marie J, Boivin P (1975) A G6PD variant with heterozygous expression in blood cells of a woman with primary myelofibrosis. Humangenetik 30:41

    PubMed  CAS  Google Scholar 

  64. Kiladjian JJ, Elkassar N, Hetet N, Brière J (1997) Study of the thrombopoietin receptor in essential thrombocytemia. Leukemia 11:1821

    PubMed  CAS  Google Scholar 

  65. Kimura A, Katoh O, Kuramoto A (1988) Effects of platelet derived growth factor, epidermal growth factor and transforming growth factor-β on the growth of human marrow fibroblasts. Br J Haematol 68:9

    Google Scholar 

  66. Klagsbrun M (1989) The fibroblast growth factor family: structural and biological properties. Prog Growth Factor Res 1:207

    PubMed  CAS  Google Scholar 

  67. Kobayashi S, Teramura M, Hoshino S, Motoji T, Oshimi K, Mizoguchi H (1993) Circulating megakaryocyte progenitors in myeloproliferative disorders are hypersensitive to interleukin-3. Br J Haematol 83:539

    PubMed  CAS  Google Scholar 

  68. Kreipe H, Jacquet K, Feigner J, Radzun HJ, Parwaresch MR (1991) Clonal granulocytes and bone marrow cells in the cellular phase of agnogenic myeloid metaplasia. Blood 78:1814

    PubMed  CAS  Google Scholar 

  69. Lagneaux L, Delforge A, Bron D, Massy M, Bernier M, Stryckmans P (1997) Heterogenous response of B lymphocytes to transforming growth factor-beta in B-cell chronic lymphocytic leukaemia: correlation with the expression of TGF-beta receptors. Br J Haematol 97:617

    Google Scholar 

  70. Laiho M, Saksela O, Keski-Oja J (1987) Transforming growth factor-β induction of type-1 plasminogen activator inhibitor. J Biol Chem 262:17467

    PubMed  CAS  Google Scholar 

  71. Lardon F, Snoeck HW, Nijs G, Lenjou M, Peetermans ME, Rodrigus I, Berneman ZN, Van Bockstaele DR (1994) Transforming growth factor-β regulates the cell cycle status of interleukin-3 (IL-3) plus IL1, stem cell factor, or IL-6 stimulated CD34+ human hematopoietic progenitor cells through different cell kinetic mechanisms depending on the applied stimulus. Exp Hematol 22:903

    PubMed  CAS  Google Scholar 

  72. Lazlo J (1975) Myeloproliferative myelosclerosis, extramedullary hematopoiesis, undifferentiated MPD and hemorrhagic thrombocythemia. Serum Hematol 12:409

    Google Scholar 

  73. Le Bousse-Kerdilès MC, Chevillard S, Charpentier A, Romquin N, Clay D, Smadja-Joffe F, Praloran V, Dupriez B, Demory JL, Jasmin C, Martyré MC (1996) Differential expression of transforming growth factor-β, basic fibroblast growth factor and their receptors in CD34+ hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia. Blood 88:4534

    PubMed  Google Scholar 

  74. Le Bousse-Kerdilès MC, Smadja-Joffe F, Klein B, Caillou B, Jasmin C (1980) Study of a virusinduced myeloproliferative syndrome associated with tumor formation in mice. Eur J Cancer 16:43

    PubMed  Google Scholar 

  75. Le Bousse-Kerdilès MC, Souyri M, Smadja-Joffe F, Praloran V, Jasmin C, Zittener HJ (1992) Enhanced hematopoietic growth factor production in an experimental myeloproliferative syndrome. Blood 79:3179

    PubMed  Google Scholar 

  76. Li M, Hatzfeld A, Brown EL, Sookdeo H, Panterne B, Levesque JP, O'Toole T, Clark SC, Hatzfeld J (1991) Autocrine transforming growth factor-β controls G0 phase of early human hematopoietic progenitors in serum- or serum-free culture. Murphy MJ Jr (ed) Blood cell growth factors. AlphaMed, Dayton, p 228

    Google Scholar 

  77. Lin HY, Wang XF, Ng-Eaton E, Weinberg RA, Lodish HF (1992) Expression cloning of the TGF-β-type II receptor, a functional transmembrane serine/threonine kinase. Cell 68:775

    PubMed  CAS  Google Scholar 

  78. Lofvenberg E, Wahlin A, Roos G, Ost A (1990) Reversal of myelofibrosis by hydroxyurea. Fur J Haematol 44:33

    CAS  Google Scholar 

  79. Lok S, Kaushansky K, Holly RD, Kujiper JL, Lofton-Day CE, Oort PJ, Grant FJ, Heipel MD, Burkhead SK, Kramer JM, Bell LA, Sprecher CA, Blumberg H, Johnson R, Prunkard D, Ching AFT, Mathewes SL, Beiley MC, Forstrom JW, Buddle MM, Osborn SG, Evans SJ, Shezppard PO, Presnell SR, O'Hara PJ, Hagen FS, Roth GJ, Foster DC (1994) Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 369:565

    PubMed  CAS  Google Scholar 

  80. Lopez-Casillas F, Cheifetz S, Doody J, Andres JL, Lane WS, Massagué J (1991) Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor system. Cell 67:785

    PubMed  CAS  Google Scholar 

  81. Manoharan A (1988) Myelofibrosis: prognostic factors and treatment. Br J Haematol 69:295

    PubMed  CAS  Google Scholar 

  82. Manoharan A (1998) Idiopathic myelofibrosis: a clinical review. Int J Hematol 68:355

    PubMed  CAS  Google Scholar 

  83. Marcus RE, Hibbin JA, Matutes E, Whittle N, Waterfield MD, Goldman JM (1986) Megakaryoblastic transformation of myelofibrosis with expression of c-sis oncogene. Scand J Haematol 36:186

    PubMed  CAS  Google Scholar 

  84. Martyré MC (1995) TGF-β and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders. Leuk Lymphoma 20:39

    PubMed  Google Scholar 

  85. Martyré MC, Le Bousse-Kerdilès C, Romquin N, Chevillard S, Praloran V, Demory JL, Dupriez B (1997) Elevated levels of basic growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis. Br J Haematol 97:441

    PubMed  Google Scholar 

  86. Martyré MC, Magdelenat H, Bryckaert MC, Laine-Bidron C, Calvo F (1991) Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-β in patients with myelofibrosis with myeloid metaplasia. Br J Haematol 77:80

    PubMed  Google Scholar 

  87. Martyré MC, Magdelenat H, Calvo F (1991) Interferon-gamma in vivo reverses the increased platelet levels of platelet-derived growth factor and transforming growth factor-β in patients with myelofibrosis with myeloid metaplasia. Br J Haematol 77:431

    PubMed  Google Scholar 

  88. Martyré MC, Romquin N, Le Bousse-Kerdilès C, Chevillard S, Benyahia B, Dupriez B, Demory JL, Banters F (1994) Transforming growth factor-β and megakaryocytes in the pathogenesis of idiopathic myelofibrosis. Br J Haematol 88:9

    PubMed  Google Scholar 

  89. Massague J (1990) The transforming growth factor-β family. Annu Rev Cell Biol 6:597

    PubMed  CAS  Google Scholar 

  90. Methia N, Louache P, Vainchenker W, Wendling F (1993) Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood 82:1385

    Google Scholar 

  91. Mignatti P, Rifkin DB (1991) Release of basic fibroblast growth factor, and angiogenic factor devoid of secretory signal sequence: a trivial phenomenon or a novel secretion mechanism. J Cell Biochem 47:201

    PubMed  CAS  Google Scholar 

  92. Moliterno A, Hankins W, Spivak J (1998) Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. N Engl J Med 338:572

    PubMed  CAS  Google Scholar 

  93. Moscatelli D (1988) Metabolism of receptor-bound and matrix-bound basic fibroblast growth factor by bovine capillary endothelial cells. J Cell Biol 107:753

    PubMed  CAS  Google Scholar 

  94. Njoku OS, Lewis SM, Catovsky D, Gordon-Smith EC (1983) Anaemia in myelofibrosis: its value in prognosis. Br J Hematol 54:79

    CAS  Google Scholar 

  95. Novetsky A, Wang JC, Chen C (1997) Plasma VEGF levels in patients with primary myelofibrosis and other myeloproliferative disorders. Blood 90

  96. Ohwada A, Rafii S, Moore MAS, Crystal RG (1996) In vivo adenovirus vector-mediated transfer of the human thrombopoietin cDNA maintains platelet levels during radiation- and chemotherapyinduced bone marrow suppression. Blood 88:778

    PubMed  CAS  Google Scholar 

  97. Oliver LJ, Rifkin DB, Gabrilove JL, Hannocks MJ, Wilson EL (1990) Long-term culture of human bone marrow stromal cells in the presence of basic fibroblast growth factor. Growth Factors 3:231

    PubMed  CAS  Google Scholar 

  98. Parmeggiani L, Ferrant A, Rodhain J, Michaux JL, Sokal G (1987) Alpha interferon in the treatment of symptomatic myelofibrosis with myeloid metaplasia. Eur J Haematol 39:228

    PubMed  CAS  Google Scholar 

  99. Pearson CA, Pearson D, Shibahara S, Hofsteenge J, Chiquet-Ehrismann R (1988) Tenascin: cDNA cloning and induction by TGF-β. EMBO J 7:2977

    PubMed  CAS  Google Scholar 

  100. Rameshwar P, Denny TN, Stein D, Gascon P (1994) Monocyte adhesion in patients with bone marrow fibrosis is required for the production of fibrogenic cytokines. Potential role for interleukin-1 and TGF-β. J Immunol 153:2819

    PubMed  CAS  Google Scholar 

  101. Reilly JT (1994) Pathogenesis of idiopathic myelofibrosis: present status and future directions. Br J Haematol 88:1

    PubMed  CAS  Google Scholar 

  102. Reilly JT (1997) Idiopathic myelofibrosis: pathogenesis, natural history and management. Blood Rev 11:233

    PubMed  CAS  Google Scholar 

  103. Reilly JT, Barnett D, Dolan G, Forrest P, Eastham J, Smith A (1993) Characterisation of an acute micromegakaryocytic leukaemia: evidence for the pathogenesis of myelofibrosis. Br J Haematol 83:58

    PubMed  CAS  Google Scholar 

  104. Reilly JT, Snowden JA, Spearing RL, Fitzgerald PM, Jones N, Watmore A, Potter A (1997) Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: a study of 106 cases. Br J Haematol 98:96

    PubMed  CAS  Google Scholar 

  105. Rupoli S, Da Lio L, Sisti S, Campanati G, Brianzoni MF, D'Amico S, Cinciripini A, Leoni (1994) Primary myelofibrosis: a detailed statistical analysis of the clinicopathological variables influencing survival. Ann Hematol 68:205

    PubMed  CAS  Google Scholar 

  106. Sato Y, Suda T, Suda J (1986) Multilineage expression of haemopoietic precursors with abnormal clone in idiopathic myelofibrosis. Br J Haematol 64:657

    PubMed  CAS  Google Scholar 

  107. Sing GK, Keller JR, Ellingsworth LR, Ruscetti FW (1988) Transforming growth factor β selectively inhibits normal and leukemic human bone marrow cell growth in vitro. Blood 72:1504

    PubMed  CAS  Google Scholar 

  108. Smadja-Joffe F, Legras S, Li Y, Girard N, Delpech B, Morimoto K, Le Bousse-Kerdilès C, Jasmin C, Levesque JP (1996) CD44 and hyaluronan binding by human myeloid cells. Leuk Lymphoma 21:407

    PubMed  CAS  Google Scholar 

  109. Taksin AL, Le Couedic JP, Dusanter-Fourt I, Massé A, Giraudier, Katz A, Wendling F, Vainchenker W, Casadevall N, Debili N (1998) Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L. Blood 93:125

    Google Scholar 

  110. Tefferi A, Silverstein MN (1994) Recombinant human erythropoietin Therapy in patients with myelofibrosis with myeloid metaplasia. Br J Haematol 86:893

    PubMed  CAS  Google Scholar 

  111. Tefferi A, Silverstein MN (1996) Current perspective in angogenic myeloid metaplasia. Leuk Lymphoma 22:169

    PubMed  Google Scholar 

  112. Terui T, Niitsu Y, Mahara K, Fujisaki Y, Urushizaki Y, Mogi Y, Kohgo Y, Watanabe N, Ogura M, Saito H (1990) The production of transforming growth factor-β in acute megakaryoblastic leukemia and its possible implication in myelofibrosis. Blood 75:1540

    PubMed  CAS  Google Scholar 

  113. Thiele J, Braeckel C, Wagner S (1992) Macrophages in normal human bone marrow and in chronic myeloproliferative disorders: an immunohistochemical and morphometric study by a new monoclonal antibody (PG-M1) on trephine biopsies. Virchows Arch [A] 421:33

    CAS  Google Scholar 

  114. Thiele J, Kvasnicka HM, Werden C, Zancovich R, Diehl V, Fischer R (1996) Idiopathic primary osteo-myelofibrosis: a clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythaemia and variables of prognosis impact. Leuk Lymphoma 22:303

    PubMed  CAS  Google Scholar 

  115. Thiele J, Kuemmel T, Sander C, Fisher R (1991) Ultrastructure of the bone marrow tissue in socalled primary (idiopathic) myelofibrosis-osteomyelosclerosis (agnogenic myeloid metaplasia). 1. Abnormalities of megakaryopoiesis and thrombocytes. J Subsmicrosc Cytol Pathol 23:93

    CAS  Google Scholar 

  116. Thomas DA, Aguayo A, Giles F, Albitar M, O'Brien S, Cortes J, Faderl S, Bivins C, Zeldis J, Keating MJ, Barlogie B, Kantarjian HM (1999) Thalidomide anti-angiogenesis therapy (RX) in Philadelphia (Ph)-negative myeloproliferative disorders (MPD) and myelofibrosis (MF) [abstract]. Blood 94:3102

    Google Scholar 

  117. Tsai JC, Goldman CK, Gillepsie GY (1995) Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF, and bFGF. J Neurosurg 82:864

    PubMed  CAS  Google Scholar 

  118. Varki A, Lottenberg R, Griffith R, Reinhard R (1983) The syndrome of idiopathic myelofibrosis: a clinicopathologic review with emphasis on the prognostic variables predicting survival. Medicine 62:353

    PubMed  CAS  Google Scholar 

  119. Vigon I, Mornon JP, Cocault L, Mitjavila MT, Tambourin P, Gisselbrecht S, Souyri M (1992) Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sci USA 89:5640

    PubMed  CAS  Google Scholar 

  120. Villeval JL, Cohen-Solal K, Tulliez M, Giraudier S, Guichard J, Burstein SA, Cramer EM, Vainchenker W, Wendling F (1997) High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice. Blood 90:4369

    PubMed  CAS  Google Scholar 

  121. Wang JC, Chen C, Lou LH, Mora M (1997) Blood thrombopoietin, IL-6 and IL-11 levels in patients with agnogenic myeloid metaplasia. Leukemia 11:1827

    PubMed  CAS  Google Scholar 

  122. Wang JC, Lang HD, Lichter S, Weinstein M, Benn P (1992) Cytogenetic studies of bone marrow fibroblasts cultured from patients with myelofibrosis and myeloid metaplasia. Br J Haematol 80:184

    PubMed  CAS  Google Scholar 

  123. Ward HP, Block MH (1971) The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine 50:357

    PubMed  CAS  Google Scholar 

  124. Weinstein IM (1991) Idiopathic myelofibrosis: historical review, diagnosis and management. Blood Rev 5:98

    PubMed  CAS  Google Scholar 

  125. Wilson EL, Rifkin DB, Kelly F, Hannocks MJ, Gabrilove JL (1991) Basic fibroblast growth factor stimulates myelopoiesis in long-term human bone marrow cultures. Blood 77:954

    PubMed  CAS  Google Scholar 

  126. Wolf BC, Neiman RS (1987) Hypothesis: splenic filtration and the pathogenesis of extramedullary hematopoiesis in agnogenic myeloid metaplasia. Hum Pathol 1:77

    CAS  Google Scholar 

  127. Wrana JL, Attisano L, Wieser R, Ventura F, Massagué J (1994) Mechanism of activation of the TGF-β receptor. Nature 370:341

    PubMed  CAS  Google Scholar 

  128. Yan XQ, Lacey D, Fletcher F, Hartley C, McElroy P, Sun Y, Xia M, Mu S, Seris S, Hill D, Hawley RG, McNiece IK (1995) Chronic exposure to retroviral vector encoded MGDF (mp1-ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice. Blood 86:4025

    PubMed  CAS  Google Scholar 

  129. Yan XQ, Lacey D, Hill D, Chen Y, Fletcher F, Hawly RG, McNiece IK (1996) A model of myelofibrosis and osteomyelosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): reversal of disease by bone marrow transplantation. Blood 88:402

    PubMed  CAS  Google Scholar 

  130. Zauli G, Visani G, Catani L, Vianelli N, Gugliotta L, Capitani S (1993) Reduced responsiveness of bone marrow megakaryocyte progenitors to platelet-derived transforming growth factor β1, produced in normal amounts, in patients with essential thrombocythaemia. Br J Haematol 83:14

    PubMed  CAS  Google Scholar 

  131. Zhou W, Toombs CF, Zou T, Guo J, Robinson MO (1997) Transgenic mice overexpressing human c-mpl ligand exhibit chronic thrombocytosis and display enhanced recovery from 5-fluorouracil or antiplatelet serum treatment. Blood 89:1551

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. INSERM U268, Hôpital Paul Brousse, 14 Avenue Paul-Vaillant Couturier, 94800, Villejuif, France

    M. C. Le Bousse-Kerdilès

  2. INSERM U365, Institut Curie, 26 Rue d'Ulm, 75231, Paris Cedex 05, France

    M. C. Martyré

Authors
  1. M. C. Le Bousse-Kerdilès
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. C. Martyré
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

Members of the French INSERM Research Network on Myelorbrosis with Myeloid Metaplasia

Rights and permissions

Reprints and permissions

About this article

Cite this article

Le Bousse-Kerdilès, M.C., Martyré, M.C. & Members of the French INSERM Research Network on Myelorbrosis with Myeloid Metaplasia. Myelofibrosis: pathogenesis of myelofibrosis with myeloid metaplasia. Springer Semin Immunopathol 21, 491–508 (2000). https://doi.org/10.1007/BF00870307

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00870307

Keywords

Search

Navigation